amino retatrutide 💠 (Reta) is a synthetic peptide-based drug composed of 39 acids. It was developed by Eli Lilly and is being studied extensively as a treatment for obesity and metabolic diseases RETATRUTIDE (RETA) – Research Peptide

As we age, natural levels of glutathione decline due to stress, toxins, illness, and ageing itself - leaving the body more vulnerable to damage and disease

Several significant metabolite-microbe relationships were also revealed, including the glycine strong positive association with Clostridium (Zhuang et al., 2018) and homocysteine positive correlation with Lachnospira , Clostridium , and Haemophilus and its negative correlation with Corynebacterium and Lachnospiraceae (Zhuang et al., 2018)

One such Mab, can block thyroid-stimulating antibodies and may be able to prevent the effect on thyroid in Graves disease [20]

Research indicates that the metabolic reprogramming of tumor cells leads to the overproduction and accumulation of ammonium, which directly disrupts immune cell functions, inhibiting T cell proliferation and cytotoxicity (112)

Recent studies published in 2024 show an increased risk of NAION, particularly in patients using these drugs for weight loss

Learn how it works and how to use it, and it can be a great tool to have in your arsenal